⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TVTX News
Travere Therapeutics, Inc. Common Stock
Travere Therapeutics to Report Second Quarter 2026 Financial Results
businesswire.com
TVTX
Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm
prnewswire.com
TVTX
Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm
globenewswire.com
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
TVTX
Form 8-K
sec.gov
TVTX
Form 8-K
sec.gov
TVTX
Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027
businesswire.com
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
TVTX
Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63 rd European Renal Association (ERA) 2026 Congress
businesswire.com
TVTX
Form 8-K
sec.gov
TVTX